Structural basis of prion inhibition by phenothiazine compounds. 2014

Pravas Kumar Baral, and Mridula Swayampakula, and Manoj Kumar Rout, and Nat N V Kav, and Leo Spyracopoulos, and Adriano Aguzzi, and Michael N G James
Department of Biochemistry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2H7, Canada.

Conformational transitions of the cellular form of the prion protein, PrP(C), into an infectious isoform, PrP(Sc), are considered to be central events in the progression of fatal neurodegenerative diseases known as transmissible spongiform encephalopathies. Tricyclic phenothiazine compounds exhibit antiprion activity; however, the underlying molecular mechanism of PrP(Sc) inhibition remains elusive. We report the molecular structures of two phenothiazine compounds, promazine and chlorpromazine bound to a binding pocket formed at the intersection of the structured and the unstructured domains of the mouse prion protein. Promazine binding induces structural rearrangement of the unstructured region proximal to β1, through the formation of a "hydrophobic anchor." We demonstrate that these molecules, promazine in particular, allosterically stabilize the misfolding initiator-motifs such as the C terminus of α2, the α2-α3 loop, as well as the polymorphic β2-α2 loop. Hence, the stabilization effects of the phenothiazine derivatives on initiator-motifs induce a PrP(C) isoform that potentially resists oligomerization.

UI MeSH Term Description Entries
D010640 Phenothiazines Compounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.
D011328 Prions Small proteinaceous infectious particles which resist inactivation by procedures that modify NUCLEIC ACIDS and contain an abnormal isoform of a cellular protein which is a major and necessary component. The abnormal (scrapie) isoform is PrPSc (PRPSC PROTEINS) and the cellular isoform PrPC (PRPC PROTEINS). The primary amino acid sequence of the two isoforms is identical. Human diseases caused by prions include CREUTZFELDT-JAKOB SYNDROME; GERSTMANN-STRAUSSLER SYNDROME; and INSOMNIA, FATAL FAMILIAL. Mink Encephalopathy Virus,Prion,Encephalopathy Virus, Mink
D011395 Promazine A phenothiazine with actions similar to CHLORPROMAZINE but with less antipsychotic activity. It is primarily used in short-term treatment of disturbed behavior and as an antiemetic. Promazine Hydrochloride,Protactyl,Sinophenin,Sparine,Hydrochloride, Promazine
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011489 Protein Denaturation Disruption of the non-covalent bonds and/or disulfide bonds responsible for maintaining the three-dimensional shape and activity of the native protein. Denaturation, Protein,Denaturations, Protein,Protein Denaturations
D002746 Chlorpromazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. Aminazine,Chlorazine,Chlordelazine,Chlorpromazine Hydrochloride,Contomin,Fenactil,Largactil,Propaphenin,Thorazine,Hydrochloride, Chlorpromazine
D000495 Allosteric Site A site on an enzyme which upon binding of a modulator, causes the enzyme to undergo a conformational change that may alter its catalytic or binding properties. Allosteric Sites,Site, Allosteric,Sites, Allosteric
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D017433 Protein Structure, Secondary The level of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to ALPHA-HELICES; BETA-STRANDS (which align to form BETA-SHEETS), or other types of coils. This is the first folding level of protein conformation. Secondary Protein Structure,Protein Structures, Secondary,Secondary Protein Structures,Structure, Secondary Protein,Structures, Secondary Protein

Related Publications

Pravas Kumar Baral, and Mridula Swayampakula, and Manoj Kumar Rout, and Nat N V Kav, and Leo Spyracopoulos, and Adriano Aguzzi, and Michael N G James
July 2016, Cell chemical biology,
Pravas Kumar Baral, and Mridula Swayampakula, and Manoj Kumar Rout, and Nat N V Kav, and Leo Spyracopoulos, and Adriano Aguzzi, and Michael N G James
July 2002, Experimental & molecular medicine,
Pravas Kumar Baral, and Mridula Swayampakula, and Manoj Kumar Rout, and Nat N V Kav, and Leo Spyracopoulos, and Adriano Aguzzi, and Michael N G James
May 2023, Nature chemical biology,
Pravas Kumar Baral, and Mridula Swayampakula, and Manoj Kumar Rout, and Nat N V Kav, and Leo Spyracopoulos, and Adriano Aguzzi, and Michael N G James
March 2013, Structure (London, England : 1993),
Pravas Kumar Baral, and Mridula Swayampakula, and Manoj Kumar Rout, and Nat N V Kav, and Leo Spyracopoulos, and Adriano Aguzzi, and Michael N G James
May 2007, Journal of molecular biology,
Pravas Kumar Baral, and Mridula Swayampakula, and Manoj Kumar Rout, and Nat N V Kav, and Leo Spyracopoulos, and Adriano Aguzzi, and Michael N G James
March 2013, Angewandte Chemie (International ed. in English),
Pravas Kumar Baral, and Mridula Swayampakula, and Manoj Kumar Rout, and Nat N V Kav, and Leo Spyracopoulos, and Adriano Aguzzi, and Michael N G James
September 2007, Nature,
Pravas Kumar Baral, and Mridula Swayampakula, and Manoj Kumar Rout, and Nat N V Kav, and Leo Spyracopoulos, and Adriano Aguzzi, and Michael N G James
December 2005, Nature structural & molecular biology,
Pravas Kumar Baral, and Mridula Swayampakula, and Manoj Kumar Rout, and Nat N V Kav, and Leo Spyracopoulos, and Adriano Aguzzi, and Michael N G James
August 2021, International journal of molecular sciences,
Pravas Kumar Baral, and Mridula Swayampakula, and Manoj Kumar Rout, and Nat N V Kav, and Leo Spyracopoulos, and Adriano Aguzzi, and Michael N G James
April 2018, Molecular cell,
Copied contents to your clipboard!